Molluscum contagiosum

VRCA DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Verrica Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important August 5 Deadline in Securities Class Action – VRCA

Retrieved on: 
Friday, July 29, 2022
Titan, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Cantharidin, Court, Food, Twitter, Class, Molluscum contagiosum, WHY, Advertising, New Drug Application, NASDAQ, THE, Facebook, I-Space (Chinese company), LinkedIn, Lists of schools in England, TO, Security (finance), Insurance, Tobacco

WHAT TO DO NEXT: To join the Verrica class action, go to https://rosenlegal.com/submit-form/?case_id=6828 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Verrica class action, go to https://rosenlegal.com/submit-form/?case_id=6828 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)

Retrieved on: 
Friday, July 29, 2022
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Time, GLOBE, Court, Food, VP, CMO, NDA, New Drug Application, NASDAQ, Endpoint security, News, Molluscum contagiosum, Defendant, Lists of schools in England, GPM, Suite, LLC, Pharmaceutical industry, Animal, Risk management

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • In December 2020, Verrica submitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking regulatory approval of VP-102 for the treatment of molluscum.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

APYX, APPS & VRCA Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Top Class Action Firm, Reminds Investors to Contact the Firm and Actively Participate

Retrieved on: 
Thursday, July 28, 2022
Lists of schools in England, Complaint, Molluscum contagiosum, GLOBE, LLC, NDA, Court, Company, Defendant, Risk management, Pharmaceutical industry

NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.

Key Points: 
  • NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.
  • You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
  • That Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.

DEADLINE ALERT for IONQ, ET, APYX, VRCA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Wednesday, July 27, 2022
Transfer, Time, Investment, Tuscarawas, GLOBE, Class, Law, Telephone, Energy, People's Law Office, NDA, IonQ, Molluscum contagiosum, FERC, Company, HDD, Quantum, LLC, Suite, Security (finance), Risk management

BENSALEM, Pa., July 27, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., July 27, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals, Inc. -VRCA

Retrieved on: 
Tuesday, July 26, 2022
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, LLP, Company, GLOBE, Food, VP, CMO, NDA, New Drug Application, NASDAQ, Endpoint security, News, Molluscum contagiosum, LLC, Pomerantz, Pharmaceutical industry

NEW YORK, July 26, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Verrica Pharmaceuticals, Inc. (Verrica or the Company) (NASDAQ:VRCA).

Key Points: 
  • NEW YORK, July 26, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Verrica Pharmaceuticals, Inc. (Verrica or the Company) (NASDAQ:VRCA).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Verrica and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

DEADLINE ALERT for APYX, VRCA, APPS, and TDOC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, July 26, 2022
Time, Investment, GLOBE, Twitter, Law, NDA, Molluscum contagiosum, Company, Defendant, Lists of schools in England, Complaint, Teladoc Health, Suite, Growth, EBITDA, Mail, Risk management, Pharmaceutical industry

LOS ANGELES, July 26, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, July 26, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Law Offices of Frank R. Cruz, Los Angeles

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Teladoc, Verrica, Apyx, and Waste Management and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, July 26, 2022
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Negotiation, New Drug Application, News, Company, Lists of schools in England, Waste Management (corporation), Teladoc Health, LLC, SMR, EBITDA, Acquisition, Tripura Merger Agreement, Walmart, Prospectus, Molluscum contagiosum, Defendant, DOJ, Growth, Office of Inspector General, U.S. Department of Health and Human Services, Waste management, GLOBE, Industry, Food, Disclosure, CMO, Failure, U.S. Department of Justice Office of Legislative Affairs, Endpoint security, D2C, Mergers and acquisitions, FDA, Amazon (company), Tax, GFL Environmental, BetterHelp, Advanced Energy, Energy Products Inc, NYSE, NDA, NASDAQ, Mental health, P.C, Coagulation, TDOC, Depreciation, Risk management, Pharmaceutical industry, Audit, Animal, Bank, Note

Throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.

Key Points: 
  • Throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.
  • In the Notes prospectus, Waste Management represented that the Merger would close by the first quarter of 2020.
  • For more information on the Waste Management class action go to: https://bespc.com/cases/WM
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action – VRCA

Retrieved on: 
Monday, July 25, 2022
Titan, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, GLOBE, Cantharidin, Court, Food, Twitter, Class, Molluscum contagiosum, WHY, Advertising, New Drug Application, NASDAQ, THE, Facebook, I-Space (Chinese company), LinkedIn, Lists of schools in England, TO, Insurance, Tobacco

WHAT TO DO NEXT: To join the Verrica class action, go to https://rosenlegal.com/submit-form/?case_id=6828 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Verrica class action, go to https://rosenlegal.com/submit-form/?case_id=6828 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)

Retrieved on: 
Friday, July 22, 2022
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Time, GLOBE, Court, Food, VP, CMO, NDA, New Drug Application, NASDAQ, Endpoint security, News, Molluscum contagiosum, Defendant, Lists of schools in England, GPM, Suite, LLC, Pharmaceutical industry, Animal, Risk management

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • In December 2020, Verrica submitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking regulatory approval of VP-102 for the treatment of molluscum.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action – VRCA

Retrieved on: 
Thursday, July 21, 2022
Titan, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, GLOBE, Cantharidin, Court, Food, Twitter, Class, Molluscum contagiosum, WHY, Advertising, New Drug Application, NASDAQ, THE, Facebook, I-Space (Chinese company), LinkedIn, Lists of schools in England, TO, Insurance, Tobacco

WHAT TO DO NEXT: To join the Verrica class action, go to https://rosenlegal.com/submit-form/?case_id=6828 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Verrica class action, go to https://rosenlegal.com/submit-form/?case_id=6828 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.